Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Return on Equity (2020 - 2026)

BioScience Health Innovations has reported Return on Equity over the past 7 years, most recently at 0.0% for Q1 2026.

  • Quarterly Return on Equity fell 1.0% to 0.0% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.0% through Mar 2026, down 1.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.
  • Return on Equity was 0.0% for Q1 2026 at BioScience Health Innovations, down from 0.0% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.11% in Q3 2023 and troughed at 2.73% in Q4 2023.
  • The 5-year median for Return on Equity is 0.0% (2024), against an average of 0.16%.
  • Year-over-year, Return on Equity dropped -10bps in 2022 and then surged 273bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.05% in 2022, then crashed by -5453bps to 2.73% in 2023, then surged by 100bps to 0.0% in 2024, then soared by 196bps to 0.0% in 2025, then tumbled by -349bps to 0.0% in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Return on Equity are 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).